Author:
Syrovatko Matej,Laznickova Alice,Laznicek Milan,Wsol Vladimir
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference15 articles.
1. Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma☆☆☆★
2. Determination of zafirlukast, a selective leukotriene antagonist, human plasma by normal-phase high-performance liquid chromatography with fluorescence detection
3. Determination of Pranlukast and its metabolites in human plasma by LC/MS/MS with PROSPEKTTM on-line solid-phase extraction
4. A.S. Leciva Prague, M. Kuchar, V. Kmonicek, V. Panajotova, B. Brunova, A. Jandera, H. Jirickova, V. Bucharova, US Patent and Trademark Office, 6303612, (16 October 2001), 25 pp.
5. Zafirlukast: The First Leukotreene-Receptor Antagonist Approved for the Treatment of Asthma
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献